Latest Hikma News & Updates

See the latest news and media coverage for Hikma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Hikma

Global generics and specialty pharmaceutical company

hikma.com

Headquarters: London, United Kingdom
Founded year: 1978
Company type: Public company
Number of employees: 10,000–11,000
Industry: Pharmaceuticals

Last updated October 19

Latest news about Hikma

In short: Hikma won a unanimous US Supreme Court patent case and reported solid H1 results and launches.

Company announcements

September 24 Hikma

Hikma appoints Rebecca Hall as new Chief Financial Officer

Hall joins from ViiV Healthcare in Q1 2027, replacing Khalid Nabilsi on December 31, 2026. She brings extensive finance leadership experience.

September 16 Hikma

Hikma launches Glucentra generic semaglutide in Saudi Arabia

Glucentra is the first generic semaglutide available to patients in the Kingdom. Hikma serves as exclusive commercialization partner for MENA.

September 9 Hikma

Hikma secures global regulatory review for an investigational medicine

Regulatory authorities in North America and Europe will evaluate the drug as the company expands affordable patient access worldwide.

August 6 Hikma

Hikma Reports half-year results with strong growth and maintains full-year guidance

Sales rise with EBIT up nearly 8%. The CEO confirms stabilization of the injectable business and reaffirms full-year targets despite MENA uncertainties.

Media coverage

October 19 DrugPatentWatch

Drug Patent Expiration: The Hidden Work Before a Generic Launch - DrugPatentWatch – Transform Data into Market Domination

On June 4, 2026, the Supreme Court decided Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889. The Court was unanimous. Justice Jackson wrote...

September 24 RTTNews

Hikma Pharmaceuticals CFO Khalid Nabilsi To Step Down; Appoints Rebecca Hall As Successor

Hikma Pharmaceuticals plc ( HKMPY ,HIK.L), a pharmaceutical company, on Thursday announced that Chief Financial Officer Khalid Nabilsi will step down from the Board on...

September 16 Drug Store News

Hikma launches first generic version of Ozempic for patients in Saudi Arabia | Drug Store News

Glucentra is a prescription medication containing the active ingredient semaglutide, a GLP-1 receptor agonist primarily prescribed to adults with Type 2 diabetes.

September 16 Ad Hoc News

Hikma stock edges higher on solid interim earnings and steady guidance

Hikma stock trades moderately higher on September 19, 2026 after the company reported solid first half 2026 revenue growth and maintained its full year guidance...

Never miss news about Hikma

Track Hikma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Hikma competitors & trending companies

Browse news for competitors to Hikma and other trending companies.